Last reviewed · How we verify

NCT03453970: Edep-Ti

Effectiveness of a Diabetes Education Program Based on Tailored Interventions (Edep-Ti Study)

Completed NA Last updated 29 July 2025
What this trial tests

NA trial testing Therapeutic Education Program in Diabetes Mellitus, Type 2 in 410 participants. Completed in 31 December 2021.

Timeline
1 December 2018
Primary endpoint
1 December 2021
31 December 2021

Quick facts

Lead sponsorUniversity of Malaga
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment410
Start date1 December 2018
Primary completion1 December 2021
Estimated completion31 December 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaga

Who can join

Adults 18 to 75, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

GOALS: PRIMARY: 1. Analyze the overall impact of the proposed diabetes education program on metabolic control (HbA1c) and modifiable cardiovascular risk factors (lipid profile and blood pressure). SECONDARY: 2. Evaluate the effectiveness of the program on smoking habits and body mass index (weight, height). 3. Analyze the impact of the program on the quality of life related to health. 4. Check the effect on lifestyles: compliance levels of physical exercise and adherence to diet mediterranean. DESIGN: Cluster randomized controlled trial

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Therapeutic Education Program

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

Other University of Malaga trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03453970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing